Metastatic patterns and outcomes by HER2 and hormone receptor (HR) status in patients (pts) with metastatic breast cancer (mBC). UGT1A1 *28/*28 genotype and risk of toxicity and disease progression in ...
Identification of thymosin beta 15 A (TMSB15A) mRNA expression as a predictor for response to neoadjuvant chemotherapy in patients with operable breast cancer. Background: To elucidate candidate genes ...